Genomic editing tools to model human diseases with isogenic pluripotent stem cells

Huen Suk Kim, Jeffrey M. Bernitz, Dung Fang Lee, Ihor R. Lemischka

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Abstract

Patient-specific induced pluripotent stem cells (iPSCs) are considered a versatile resource in the field of biomedicine. As iPSCs are generated on an individual basis, iPSCs may be the optimal cellular material to use for disease modeling, drug discovery, and the development of patient-specific cellular therapies. Recently, to gain an in-depth understanding of human pathologies, patient-specific iPSCs have been used to model human diseases with some iPSC-derived cells recapitulating pathological phenotypes in vitro. However, complex multigenic diseases generally have not resulted in concise conclusions regarding the underlying mechanisms of disease, in large part due to genetic variations between disease-state and control iPSCs. To circumvent this, the use of genomic editing tools to generate perfect isogenic controls is gaining momentum. To date, DNA binding domain-based zinc finger nucleases and transcription activator-like effector nucleases have been utilized to create genetically defined conditions in patient-specific iPSCs, with some examples leading to the successful identification of novel mechanisms of disease. As the feasibility and utility of genomic editing tools in iPSCs improve, along with the introduction of the clustered regularly interspaced short palindromic repeat system, understanding the features and limitations of genomic editing tools and their applications to iPSC technology is critical to expending the field of human disease modeling.

Original languageEnglish
Pages (from-to)2673-2686
Number of pages14
JournalStem Cells and Development
Volume23
Issue number22
DOIs
StatePublished - 15 Nov 2014

Fingerprint

Dive into the research topics of 'Genomic editing tools to model human diseases with isogenic pluripotent stem cells'. Together they form a unique fingerprint.

Cite this